Electronic Medical Record Reminders Improve HBV Vaccination in Diabetics
Investigators assessed vaccination rates for hepatitis B vaccine series with electronic provider reminders in adults with diabetes.
All articles by Virginia Schad, PharmD
Hepatitis B Infection May Increase the Risk for Pancreatic Cancer
Investigators assessed the association of hepatitis B infection and pancreatic cancer, along with predictors of pancreatic cancer and mortality.
Diabetes Risk Associated With Cirrhosis, Not Chronic HCV Infection, in HIV+ Patients
Cirrhosis is associated with an increased risk for diabetes mellitus among patients living with HIV.
Successful Hepatitis C Treatment May Reduce Risk for Developing T2D
Among a large US cohort of patients treated for HCV, patients who achieved sustained virologic response demonstrated a substantially lower risk for development of type 2 diabetes than patients with treatment failure.
Safety, Efficacy of Degludec/Liraglutide Fixed-Ratio Combination in Uncontrolled T2D
IDegLira provides an efficacious intensification option with noninferior glycemic control vs basal-bolus in patients with type 2 diabetes receiving 20 to 50 units of basal insulin with no renal impairment and HbA1c levels of 7% to 10%.
Low-Grade Inflammatory Markers May Help Differentiate Diabetes Diagnoses in Adults
Study provided evidence of significant differences in median serum concentrations of circulating adipose-related inflammatory biomarkers across the main diabetes types.
Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
Researchers conducted a prospective, population-based cohort study to assess the risk for cardiovascular disease in postmenopausal women with increased androgen levels.
Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Greater Bone Formation With Teriparatide vs Zoledronic Acid in Osteoporosis
Researchers have determined that treatment for osteoporosis with teriparatide is associated with greater bone formation than treatment with zoledronic acid.
No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia
Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.
Next post in ENDO 2018
